Columbia University has received a $58.4 million grant from the NIH's National Center for Advancing Translational Sciences to expand its work in translational research.
CUMC/NYP will serve as a clinical trial site for patients with food allergies as part of the Food Allergy Research & Education (FARE) Clinical Network.
According to a new report published in JAMA Oncology, women with BRCA1 mutations have a higher risk of developing an aggressive type of uterine cancer.
$4 million grant gives Columbia, Weill Cornell Medicine, NewYork-Presbyterian, and NYC Health + Hospitals key role in precision medicine cohort program.
